Thus we hypothesized that if PDE7B were upregulated in GBM cells, it might also stimulate GBM growth, and its catalytic activity might constitute a novel therapeutic target, similar to other cAMP specific phosphodiesterases [24], [25], [26]. The gene discussed is PDE7B; the disease is glioblastoma.